about
Reducing myocardial infarct size: challenges and future opportunitiesFrom basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"Age and Surgical Complexity impact on Renoprotection by Remote Ischemic Preconditioning during Adult Cardiac Surgery: A Meta analysisQuantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping.The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk).Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patientsPrognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials.Quantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging.Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction.Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance.Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients.Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance.Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled TrialsMyocardial T1 mapping.Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping.Magnetic Resonance in Transthyretin Cardiac Amyloidosis.Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging.Diagnostic performance of T1 and T2 mapping to detect intramyocardial hemorrhage in reperfused ST-segment elevation myocardial infarction (STEMI) patientsGlobal longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling.Ischaemic conditioning: are we there yet?Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality.Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?Bioresorbable stents: Current and upcoming bioresorbable technologies.Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".Reply: Meta-Analysis of the Index of Microvascular Resistance in Acute STEMI Using Incomplete Data.AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology.LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study.An instantaneous ECV with no blood sampling: using native blood T1 for hematocrit is as good as standard ECV.Redefining viability by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction.Clinical application of MOLLI T1* for extracellular volume calculation in healthy volunteers and aortic stenosis.Reply to "Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei".ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis.Response by Andrews et al to Letter Regarding Article, "Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging".
P50
Q26775395-60E2D64B-4725-4A4E-9DD4-DAF02547DBBDQ28073354-6B1ACB47-D320-426A-845C-9CF81F587692Q33671037-80A02315-0186-4612-97D9-728E6193E17EQ33720141-C2A3C703-74B0-4D68-BA6B-8A95DE97137BQ33884781-670DF74B-2886-4181-ABC3-57B52F4BE0BBQ33915452-568A9F52-083F-4C57-A277-0BD641E70814Q35810347-CA46A444-9E82-4C3A-A1A9-2009C390170CQ35945907-BD33BD18-698B-4809-8A8D-9226D398360EQ36165179-12E259CC-EB93-4012-93C3-C7D25F7634C6Q36345758-AC9D9B8F-82E0-4A70-A6FE-F184B7967DF7Q36783710-D57D6064-D3A7-44B3-9149-3EC7D83B8E80Q37240733-1AAF4B26-FAC9-4F71-A15F-C1B5752EA773Q37346530-720CEBEC-1F12-4244-9248-E085D8617E33Q37521985-48F37ECE-1A2E-4614-AE80-AB4EC5CD05CCQ37608086-F247FCC6-0A09-4974-A4D3-064276938F45Q37695032-06C94DB0-C77E-4693-AABC-B02C82D4A891Q37696752-4AE35171-6399-40BB-8088-67053F1FCC29Q38369121-E8593A22-356A-4567-822B-EB57AE839254Q38400610-C64A4D5B-0643-4351-98A1-D47608309A3FQ38400944-C396F1EB-36FB-48F4-9FE6-E6857AFDAF12Q38401116-0A201EFE-2B14-4439-896C-D8BC3F58AADFQ38405758-792DDF70-A8B2-4AEB-90E2-376F5B5F990AQ38417406-D83DC201-F9E8-43C1-BE67-732F0CCD32D1Q38418247-9E5D95B9-0E88-45D5-8F0A-728D601E5599Q38427068-EA2F945E-3EA1-484B-B73A-D7AFF2AE9490Q38631686-3DFBDACE-DA7F-4269-8315-87865F2217FEQ38752589-D8DAB0E8-8DC3-4E90-A440-D832CFC22A16Q39027311-59A0B3A5-8E21-4C02-931C-5FE10BD73B34Q40503224-8329BD53-3400-4A68-B3AF-73EEB3789AE1Q42936212-21749376-2C6B-4FF7-B8E9-8C137B4E4084Q45222478-86F31B73-E8E0-4A0C-B52F-12BE098327E0Q45778969-B980A811-ECCD-4E89-A2FF-021460AB2EABQ46412107-B872B8F1-59EF-4619-A281-C4AF5C5E2B49Q46718385-1F96C97A-1BBF-4E8E-9AFE-6C6CED453407Q47100716-706EE9DD-10FB-42B2-8A7C-91C29E15161FQ47123170-790FB35C-B5C0-40A9-8417-6B638E55C0E0Q47225876-040B6B74-1346-444A-87A0-D534E264BED6Q47261872-8B3E500C-4FB6-4B5C-840C-673E1E5D6130Q47378684-95E75859-2DAF-42AF-A517-7ADCA8F0B462Q47439097-BB3393B3-40AB-4806-B401-729AB8BCAFB4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Heerajnarain Bulluck
@ast
Heerajnarain Bulluck
@en
Heerajnarain Bulluck
@es
Heerajnarain Bulluck
@nl
Heerajnarain Bulluck
@sl
type
label
Heerajnarain Bulluck
@ast
Heerajnarain Bulluck
@en
Heerajnarain Bulluck
@es
Heerajnarain Bulluck
@nl
Heerajnarain Bulluck
@sl
prefLabel
Heerajnarain Bulluck
@ast
Heerajnarain Bulluck
@en
Heerajnarain Bulluck
@es
Heerajnarain Bulluck
@nl
Heerajnarain Bulluck
@sl
P106
P1153
53981151600
P31
P3835
heerajnarain-bulluck
P496
0000-0002-1985-1783